Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein

The IGROVCDDP cisplatin-resistant ovarian cancer cell line is also resistant to paclitaxel and models the resistance phenotype of relapsed ovarian cancer patients after first-line platinum/taxane chemotherapy. A TaqMan low-density array (TLDA) was used to characterise the expression of 380 genes ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Stordal, Britta, Hamon, Marion, McEneaney, Victoria, Roche, Sandra, Gillet, Jean-Pierre, O’Leary, John J., Gottesman, Michael, Clynes, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394717/
https://www.ncbi.nlm.nih.gov/pubmed/22792399
http://dx.doi.org/10.1371/journal.pone.0040717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394717/
https://www.ncbi.nlm.nih.gov/pubmed/22792399
http://dx.doi.org/10.1371/journal.pone.0040717

Ejemplares similares